INNO-LIPA HLA- A - INVIMA Registration 8af633d2bbb68c68174d87ab193cd0d8
Access comprehensive regulatory information for INNO-LIPA HLA- A (INNO-LIPA HLA- A) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 8af633d2bbb68c68174d87ab193cd0d8 and manufactured by QUIMIOLAB S.A.S. The device was registered on October 04, 2029.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
INNO-LIPA HLA- A MÚLTIPLEX, DE USO IN VITRO, ESTÁ DISEÑADO PARA LA AMPLIFICACIÓN DE LOS ÁCIDOS NUCLEICOS DEL PRIMERO AL CUARTO EXÓN DEL LOCUS A DEL ANTIGENO LEUCOCITARIO HUMANO (HLA). LA REACCIÓN SE LLEVA A CABO MEDIANTE LA REACCIÓN EN CADENA DE LA POLIMERASA (PCR) EN UN FORMATO MÚLTIPLE.
INNO-LIPA HLA- A MULTIPLEX, FOR IN VITRO USE, IS DESIGNED FOR ACID AMPLIFICATION NUCLEIC NUCLEIC FROM THE FIRST TO THE FOURTH EXON OF LOCUS A OF THE HUMAN LEUKOCYTE ANTIGEN (HLA). THE REACTION IT IS CARRIED OUT BY THE CHAIN REACTION OF POLYMERASE (PCR) IN A MULTIPLE FORMAT.